We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WXM:NASDAQWF International Limited Analysis

Data as of 2026-05-28 - not real-time

$0.46

Latest Price

8/10Risk

Risk Level: High

Executive Summary

WF International Limited trades at $0.46, well below its DCF‑derived fair value of $0.68, suggesting a potential undervalued entry point. The stock sits between its 20‑day SMA (0.49) and 50‑day SMA (0.49) with a neutral trend, while the RSI of 44 indicates neither overbought nor oversold conditions. However, the MACD histogram is negative and the MACD signal is bearish, pointing to short‑term downside pressure. The equity exhibits extreme 30‑day volatility (~99%) and a beta of 1.35, reflecting heightened sensitivity to market moves.
Fundamentally the company is in distress: revenue has slumped 52% year‑over‑year, gross margin is a meager 8.8% and operating margin is deeply negative at –54%. Net loss per share stands at –$0.53 and cash flow remains negative, while total debt exceeds cash on hand, driving a debt‑to‑equity ratio of 74%. Despite a low price‑to‑book of 0.67, the lack of dividend and weak profitability raise concerns about sustainability. The combination of thin liquidity, high drawdown risk (‑90% max drawdown) and concentration in the Chinese industrial distribution sector underscores a high‑risk profile.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD and negative histogram
  • Price near recent support at $0.367
  • Extreme short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Undervalued relative to DCF
  • Potential upside if turnaround improves margins
  • Continued high beta and sector exposure

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Fundamental restructuring needed to address debt and cash flow
  • Long‑run recovery in Chinese HVAC market
  • Uncertainty around sustained profitability

Key Metrics & Analysis

Financial Health

Revenue Growth-51.70%
Profit Margin-24.54%
ROE-71.91%
ROA-14.05%
Debt/Equity74.20
P/B Ratio0.7
Op. Cash Flow$-1136434
Free Cash Flow$573.5K
Industry P/E30.1

Technical Analysis

TrendNeutral
RSI44.4
Support$0.37
Resistance$0.68
MA 20$0.49
MA 50$0.49
MA 200$1.36
MACDBearish
VolumeIncreasing
Fear & Greed Index91.66

Valuation

Fair Value$0.68
GradeUndervalued
TypeValue

Risk Assessment

Beta1.35
Volatility98.80%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.